Channel Therapeutics Corporation
New York Stock Exchange ArcaTotal Valuation
Channel Therapeutics Corporation carries a market capitalization of 8.90M, placing it among publicly traded companies globally.
| Market Cap | 8.90M |
| Enterprise Value | N/A |
Share Statistics
Channel Therapeutics Corporation currently has 648,500.00 shares outstanding.
| Shares Outstanding | 648,500.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.29 |
| P/TBV Ratio | -1.19 |
| P/FCF Ratio | -3.99 |
| P/OCF Ratio | -3.99 |
Financial Position
Channel Therapeutics Corporation maintains a current ratio of 0.11, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.11 |
| Quick Ratio | 0.01 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -17.91 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -527.54 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Channel Therapeutics Corporation's stock has declined approximately -87.38318% over the past 52 weeks. The 50-day moving average sits at 12.03, while the 200-day moving average is 12.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -87.38318% |
| 50-Day Moving Average | 12.03 |
| 200-Day Moving Average | 12.00 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -8.94M, while operating income came in at -8.94M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -8.94M |
| Pretax Income | -9.04M |
| Net Income | -9.04M |
| EBITDA | -8.94M |
| EBIT | -8.94M |
| Earnings Per Share (EPS) | -14.80 |
Balance Sheet
Total book value stands at -26.89M, with working capital of -6.49M providing operational flexibility.
| Cash & Cash Equivalents | 59,172.00 |
| Total Debt | N/A |
| Net Debt | 2.25M |
| Equity (Book Value) | -26.89M |
| Book Value Per Share | -44.02 |
| Working Capital | -6.49M |
Cash Flow
Channel Therapeutics Corporation produced -1.93M in operating cash flow over the past twelve months.
| Operating Cash Flow | -1.93M |
| Capital Expenditures | N/A |
| Free Cash Flow | -1.93M |
| FCF Per Share | -3.16 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 5.44 |
| FCF Yield | -25.04 |
Stock Splits
Channel Therapeutics Corporation's most recent stock split took place on July 2, 2025 with a 10:1 split ratio.
| Last Split Date | 7/2/2025 |
| Split Ratio | 10:1 |
Scores
Channel Therapeutics Corporation posts an Altman Z-Score of -90.44, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -90.44 |